Insider Trading activities at Durata Therapeutics, Inc. (DRTX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Durata Therapeutics, Inc. (DRTX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Durata Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1544116.

Total stock buying since 2014: $320,355.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $20,940.


5 insiders reported insider trading activities at Durata Therapeutics, Inc. (DRTX):
Insider trading activities of Shannon John Patrick Jr
Insider trading activities of Edick Paul R
Insider trading activities of De Schutter Richard U
Insider trading activities of Canaan Viii Lp
Insider trading activities of Ahrens Brenton Karl

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Durata Therapeutics, Inc. (DRTX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2014 21,000 $320,355 0 $0 10,068 $20,940

Table 2. Monthly summary of insider trading at Durata Therapeutics, Inc. (DRTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2014-08 3,000 $41,160 0 $0 10,068 $20,940
2014-06 3,000 $45,690 0 $0 0 $0
2014-05 15,000 $233,505 0 $0 0 $0

Table 3. Detailed insider trading at Durata Therapeutics, Inc. (DRTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-08-26 Canaan Viii Lp (Director) Option Ex 5,034 2.08 10,470
2014-08-26 Ahrens Brenton Karl (Director) Option Ex 5,034 2.08 10,470
2014-08-12 Shannon John Patrick Jr (Chief Commercial Officer) Buy 3,000 13.72 41,160
2014-06-12 Edick Paul R (Chief Executive Officer) Buy 3,000 15.23 45,690
2014-05-12 De Schutter Richard U (Director) Buy 15,000 15.57 233,505

Insider trading activities including stock purchases, stock sales, and option exercises of DRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Durata Therapeutics, Inc. (symbol DRTX, CIK number 1544116) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.